Microbiology
Flavivirus, one of more than 60, along with Dengue and Chikungunya.
Epidemiologic Risks
Mosquito bites in sub-Saharan Africa (West > East) and South America (the Amazon basin).
Syndromes
Asymptomatic to non-specific fever to hemorrhagic fever (usually hemorrhagic fever, fulminant hepatic necrosis, and renal failure) with a predominant icterus.
Treatment
Supportive.
There is a vaccine, an attenuated virus that produces long-term immunity in greater than 95% of recipients after a single 0.5-mL subcutaneous dose.
2 - 5 days after the vaccine, first-time vaccinees can get acute MOSF and >50% died. 37 cases worldwide, mostly in older people, maybe 1:20,000 vaccine doses in the elderly, about 1:400,000 vaccine in youngerly. So your chance of dying is far greater from the disease than the vaccine.
Notes
The vaccine may exacerbate MS.
Last Update: 05/03/18.